Le Lézard
Classified in: Health
Subjects: TDS, FVT

BioMarin to Participate in Two Investor Conferences in October


SAN RAFAEL, Calif., Sept. 19, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), today announced that management will participate in two investor conferences this October.  To access the events that are accessible by live webcasts, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.

BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

Contacts:


Investors 

Media

Traci McCarty                       

Debra Charlesworth

BioMarin Pharmaceutical Inc. 

BioMarin Pharmaceutical Inc.

(415) 455-7558                         

(415) 455-7451

 

SOURCE BioMarin Pharmaceutical Inc.


These press releases may also interest you

at 08:50
HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call
HLS Therapeutics Inc. ("HLS" or the "Company") , announces that it will release its Q1 fiscal 2024 financial results on Thursday, May 9, 2024. The Company will hold a conference call that same day at 8:30 a.m. ET to discuss its results. The call will...

at 08:50
Zentiva joins the Critical Medicines Alliance to enhance EU Medicine Supply
Zentiva, a Pan-European pharmaceutical company, joined the inaugural launch of the EU's Critical Medicines Alliance, held on April 24-25 in Brussels. This significant event, organized by DG HERA and the Belgian Presidency, convened leaders from...

at 08:46
Orchid Welcomes Distinguished Clinical and Genetics Leaders to its Advisory Boards
Orchid, a reproductive technology company offering the world's only commercially available whole genome embryo screening, today announced Dr. Amber Cooper, Dr. Roohi Jeelani, and Jerry Lanchbury, Ph.D as new members joining their Medical and...

at 08:45
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
Cannabix Technologies Inc. (the "Company or Cannabix") developer of alcohol and marijuana breathalyzer screening devices for law enforcement and the workplace reports that Friedel, LLC ("Friedel Clinic") a private monitoring agency, based in...

at 08:45
Wheel to Power Owlet's New Virtual Health and Prescription Service
Wheel, the virtual care platform powering the future of care, today announced a strategic partnership with Owlet, Inc. ("Owlet") , the pioneer of smart infant monitoring. As part of this direct-to-consumer virtual offering, Wheel clinicians will...

at 08:43
Purina Parent Club Partnership Program Supports Canine Health Research Funded Through the AKC Canine Health Foundation
The AKC Canine Health Foundation (CHF), a nonprofit organization dedicated to advancing the health of all dogs and their owners, announces that Purina has donated $111,910 in support of CHF-funded canine health research thanks to its Purina Parent...

More news about Health...


News published on and distributed by: